Phase II study of S-1, a novel oral fluoropyrimidine, and biweekly administration of docetaxel for previously treated advanced non-small-cell lung cancer

Author： Oki Yasunari   Hirose Takashi   Yamaoka Toshimitsu   Kusumoto Sojiro   Shirai Takao   Sugiyama Tomohide   Okuda Kentaro   Nakashima Masanao   Murata Yasunori   Ohmori Tohru   Adachi Mitsuru  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.67, Iss.4, 2011-04, pp. : 791-797

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Phase II study of S-1 and docetaxel for previously treated patients with locally advanced or metastatic non-small cell lung cancer

By Yanagihara Kazuhiro   Yoshimura Kenichi   Niimi Miyuki   Yasuda Hiroyasu   Sasaki Takahiko   Nishimura Takafumi   Ishiguro Hiroshi   Matsumoto Shigemi   Kitano Toshiyuki   Kanai Masashi   Misawa Akiko   Tada Harue   Teramukai Satoshi   Mio Tadashi   Fukushima Masanori  

Cancer Chemotherapy and Pharmacology, Vol. 66, Iss. 5, 2010-10 ,pp. : 913-918

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of biweekly administration of docetaxel and irinotecan in patients with refractory or relapsed advanced non-small cell lung cancer

By Hirose Takashi   Shirai Takao   Ishida Hiroo   Ando Kohichi   Sugiyama Tomohide   Kusumoto Sojiro   Hosaka Takamichi   Nakashima Masanao   Ohmori Tohru   Adachi Mitsuru  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 2, 2007-07 ,pp. : 267-274

Springer Publishing Company

Access to resources Recommend Favorite

A Phase II NCCTG Study of Irinotecan and Docetaxel in Previously Treated Patients with Non-Small Cell Lung Cancer

By Molina Julian   Nikcevich Daniel   Hillman Shauna   Geyer Susan   Drevyanko Timothy   Jett James   Verdirame Joseph   Tazelaar Henry   Rowland Kendrith   Wos Edward   Kutteh Leila   Nair Suresh   Fitch Tom   Flynn Patrick   Stella Philip   Adjei Alex  

Cancer Investigation, Vol. 24, Iss. 4, 2006-07 ,pp. : 382-389

Informa Healthcare

Access to resources Recommend Favorite

Biweekly docetaxel-irinotecan with filgrastim support in pretreated breast and non-small-cell lung cancer patients. A phase I study

By Frasci Giuseppe   Comella Pasquale   Thomas Renato   Bonito Maurizio   Lapenta Liliana   Capasso Immacolata   Botti Gerardo   Vallone Paolo   Rosa Vincenzo   D'Aiuto Giuseppe   Comella Giuseppe  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 1, 2004-01 ,pp. : 25-32

Springer Publishing Company

Access to resources Recommend Favorite

Second-line docetaxel and gemcitabine combination chemotherapy in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: A phase II trial

By Tas Faruk   Demir Cumhur   Camlica Hakan   Ustuner Zeki   Topuz Erkan  

Medical Oncology, Vol. 21, Iss. 3, 2004-09 ,pp. : 233-240

Humana Press, Inc

Access to resources Recommend Favorite